Antimicrobial Susceptibility Testing for Enterococci

Journal
Journal of Clinical Microbiology
ISSN
0095-1137
1098-660X
Date Issued
2022
Author(s)
Ayesha Khan
William R. Miller
Dierdre Axell-House
Cesar A. Arias
Type
Resource Types::text::journal::journal article
Scopus ID
2-s2.0-85138457673
WoS ID
WOS:000811639900001
DOI
URL
URL Institutional Repository
Abstract
<jats:p>Enterococci are major, recalcitrant nosocomial pathogens with a wide repertoire of intrinsic and acquired resistance determinants and the potential of developing resistance to all clinically available antimicrobials. As such, multidrug-resistant enterococci are considered a serious public health threat.</jats:p>
Cite this document
Khan, A., Miller, W. R., Axell-House, D., Munita, J. M., & Arias, C. A. (2022). Antimicrobial susceptibility testing for enterococci. Journal of Clinical Microbiology, 60(9), e00843-21. https://doi.org/10.1128/jcm.00843-21
Subjects
vancomycin-resistant enterococcus

; 

level aminoglycoside resistance

; 

automated microbiology system

; 

care-associated infections

; 

skin-structure infections

; 

acute bacterial skin

; 

blood culture assay

; 

in-vitro activity

; 

broth microdilution

; 

penicillin-resistant

; 

aminoglycosides

; 

anti-bacterial agents

; 

beta-lactams

; 

daptomycin

; 

enterococcus

; 

gram-positive bacterial infections

; 

humans

; 

lipoglycopeptides

; 

microbial sensitivity tests

; 

oxazolidinones

; 

tetracycline

; 

vancomycin

; 

ampicillin

; 

antiinfective agent

; 

beta lactam

; 

carbapenemase

; 

chloramphenicol

; 

ciprofloxacin

; 

clavulanic acid

; 

cotrimoxazole

; 

dalbavancin

; 

doxycycline

; 

erythromycin

; 

gentamicin

; 

imipenem

; 

lipoglycopeptide

; 

metronidazole

; 

nitrofurantoin

; 

penicillin derivative

; 

tetracycline

; 

tobramycin

; 

vancomycin

; 

aminoglycoside

; 

antiinfective agent

; 

daptomycin

; 

oxazolidinone derivative

; 

tetracycline

; 

vancomycin

; 

antibiotic resistance

; 

antibiotic sensitivity

; 

antimicrobial activity

; 

bacterium isolate

; 

candida albicans

; 

clinical decision making

; 

clinical laboratory

; 

disk diffusion

; 

enterococcus

; 

enterococcus faecium

; 

eubacterium

; 

gene mutation

; 

gram positive bacterium

; 

haemophilus influenzae

; 

innate immunity

; 

machine learning

; 

mic50

; 

mic90

; 

minimum inhibitory concentration

; 

multilocus sequence typing

; 

nonhuman

; 

quality control

; 

review

; 

streptococcus mitis

; 

streptococcus pneumoniae

; 

enterococcus

; 

gram positive infection

; 

human

; 

microbial sensitivity test

; 

microbiology